cycloserine

(redirected from D-cycloserine)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to cycloserine

an antibiotic that is especially active against the tubercle bacillus

References in periodicals archive ?
D-cycloserine and rapastinel significantly reduced depressive symptoms without psychotomimetic and dissociative effects.
In one study of Iraq and Afghanistan veterans, the use of D-cycloserine (DCS) did not provide an advantage overall, compared with alprazolam or placebo.
EVMS' laboratory studies with the Balb/c mouse led its investigators to hypothesize that D-Cycloserine could ease the impaired sociability of persons with autism, such as avoiding eye contact and personal interaction.
Using drugs like D-cycloserine to make extinction work more broadly is a big advancement in the treatment of addiction.
The team then gave oral D-Cycloserine to some rats.
Michael Davis and Kerry Ressler of the Emory University School of Medicine and Yerkes National Primate Research Center conducted preclinical studies that demonstrated D-cycloserine helped reduce fears faster, leading to the eventual disappearance, or "extinction," of the fear(1,2).
The drug, D-cycloserine, does not work on its own but in combination with conventional 'exposure therapy', the standard form of treatment for phobias which involves exposing people to whatever it is they are afraid of.
His study involved 30 acrophobic individuals, ten of whom were given a dummy drug while the rest received either a small or a standard dose of D-cycloserine.
And scientists think antibiotic D-cycloserine could also stop people feel nervous about learning new skills.
The report includes d-cycloserine description, covers its application areas and related patterns.
Unlike most conventional antidepressant drugs which target the brain's serotonin pathway, ketamine and D-cycloserine target the brain NMDA receptor, a receptor first characterized by the inventor Prof.
Arbaclofen, intranasal oxytocin, and D-cycloserine for the treatment of core deficits in autism spectrum disorders are all moving forward to more advanced clinical trials on the basis of encouraging studies highlighted at a meeting of the New Clinical Drug Evaluation Unit sponsored by the National Institute of Mental Health.
But before you get depressed the good news is that the same research-ers have discovered a promising painkiller, d-cycloserine, which boosts the activity of brain cells and could also relieve chronic pain.
One drug of interest is d-cycloserine, which enhances the activity of a protein in the amygdala that is important for fear extinction.
I was unhappy, however, to see that the drug D-cycloserine was going to be used to help people overcome their fear of public speaking.